Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.
about
Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke.Tumor-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumor subtype.Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.Expression and prognostic value of JAM-A in gliomas.Heterogenic expression of stem cell markers in patient-derived glioblastoma spheroid cultures exposed to long-term hypoxia.
P2860
Q36234890-191C1ABF-B34F-4D89-965C-41889890DDCFQ36289595-1E3E4485-44A6-4049-B7E7-B3257CCA5258Q36809420-017B326C-F28E-4ADB-8139-DBA26BBBA4C7Q38647050-6165ED33-57F0-4E5E-AEEE-C1661107433EQ38675705-1955739E-17E2-4FFA-9F9D-9A42721DD019Q44341014-1926305C-38BF-49EE-8535-E902813112F7Q55030657-E007FF34-6226-4820-A1A1-BF4742C49E25
P2860
Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.
@en
type
label
Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.
@en
prefLabel
Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.
@en
P2093
P2860
P50
P356
P1433
P1476
Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.
@en
P2093
Ann Mari Rosager
Bjarne W Kristensen
Jacob Klitkou
Julie A Bangsø
Sigurd Fosmark
Sofie Hellwege
Stine A Petterson
P2860
P304
P356
10.2217/CNS.14.30
P577
2014-07-01T00:00:00Z